Gastro
Rabecure-DSR
Rabeprazole and domperidone combined for acid suppression and improved gastric motility.
“Complete acid control with comfortable digestion.”
Composition
- Active ingredients
- Rabeprazole (Enteric-Coated) 20 mg + Domperidone (Sustained-Release) 30 mg
- Dosage form
- Capsules
- Pack size
- 10 capsules
Indications
- GERD (Gastroesophageal Reflux Disease)
- Acid Peptic Disorder
- Gastritis
- Bloating & indigestion
- Nausea associated with acidity
Dosage snapshot
- Dosing
- Once daily, before meals
- Preferred timing
- Before breakfast
Dosage should be individualised by the prescribing physician.
Key benefits
- Dual-action therapy combining acid suppression with a prokinetic effect.
- Rapid relief from acidity, heartburn, and reflux.
- Improved gastric emptying reduces bloating and fullness.
- Enteric coating protects rabeprazole for optimal absorption.
Why this formula works
Rabecure-DSR combines a proton-pump inhibitor with a prokinetic in a single once-daily capsule: enteric-coated rabeprazole suppresses gastric acid secretion, while sustained-release domperidone improves gastric emptying and motility.
Addressing both acid output and motility together helps relieve the overlapping symptoms of reflux, gastritis, and bloating more completely than acid suppression alone, while the enteric coating and sustained-release format are designed to protect drug stability and extend the duration of action.